Exelixis Inc. (EXEL)
NASDAQ · Healthcare
Exelixis Inc. Cash Flow 2009–2026
| Jan 2026 | Jan 2025 | Dec 2023 | Dec 2022 | Dec 2021 | Jan 2021 | Jan 2020 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2016 | Jan 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Operating Cash Flow | 884.3M | 700.0M | 333.3M | 362.6M | 400.8M | 209.0M | 527.0M | 415.7M | 165.6M | 206.3M | 210.4M | -141.1M | -141.6M | -235.4M | -198.8M | -123.1M | -159.2M | -101.0M | -14.6M |
| Depreciation & Amort. | 29.1M | 28.8M | 25.7M | 20.9M | 13.6M | 9.1M | 8.3M | 4.9M | 1.2M | 1.0M | 1.0M | 1.4M | 1.4M | 2.4M | 3.1M | 5.5M | 6.8M | 10.5M | 12.6M |
| Investing Activities | |||||||||||||||||||
| Capital Expenditure | 8.4M | 28.4M | 40.5M | 27.7M | 54.2M | 30.3M | 12.8M | 33.3M | 21.1M | 1.7M | 1.7M | 447,000 | 447,000 | 474,000 | 2.2M | 2.7M | 991,000 | 1.8M | 5.9M |
| Free Cash Flow | 875.8M | 671.5M | 292.9M | 334.9M | 346.6M | 178.6M | 514.1M | 382.4M | 144.5M | 204.6M | 208.7M | -141.5M | -142.0M | -235.9M | -200.9M | -125.9M | -160.2M | -102.9M | -20.5M |
| Financing Activities | |||||||||||||||||||
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | 947.5M | 652.0M | 550.4M | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Exelixis Inc. Cash Flow — FAQ
Exelixis Inc. (EXEL) cash flow over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EXEL's cash flow history?
The chart and table above show Exelixis Inc.'s cash flow by year and by quarter, including the growth rate.